bismuth subnitrate (Roter)

01/01/2013 - "The objective of this study was to assess the efficacy of internal teat sealant products containing bismuth subnitrate (Teatseal and Orbeseal; Pfizer Animal Health, West Ryde, Australia) when used alone, or in the presence of antibiotic dry cow therapy (ADCT), before or at drying off on the incidence of new intramammary infections (IMI), clinical mastitis, and milk somatic cell count (SCC) during lactation. "
01/01/2007 - "This study investigated the effect in heifers of infusion of a bismuth subnitrate teat-canal sealant and bacterial intramammary infection (IMI) precalving on prevalence of postcalving IMI and incidence of clinical mastitis in the first 2 wk postcalving. "
09/01/2014 - "The main aim was to investigate the effectiveness of a novel internal teat sealant (ITS) formulation containing bismuth subnitrate and the antiseptic chlorhexidine, in adult cows (Trial A) and nulliparous heifers (Trial B), to reduce the incidence of new intramammary infection (IMI) between treatment and calving and reduce the prevalence of IMI within 6 days following calving. "
01/01/2008 - "This study investigated the effect of infusion of a bismuth subnitrate teat canal sealant or an injectable antibiotic, or both, in heifers on the cure of existing intramammary infection (IMI), incidence of new IMI, prevalence of postcalving IMI, and incidence of clinical mastitis in the first 2 wk postcalving at the quarter level. "
03/01/2002 - "The efficacy of an internal dry period teat sealer containing bismuth subnitrate (Product A; Teatseal, Cross Vetpharm Group Ltd, Ireland) was compared with a long-acting antibiotic preparation containing cephalonium (Product B; Cepravin Dry Cow, Schering-Plough Ltd, UK), by assessing the number of new intramammary infections (IMI) acquired during the dry period and the number of cases of clinical mastitis during the first 100 d of lactation. "

01/01/2013 - "The objective of this study was to assess the efficacy of internal teat sealant products containing bismuth subnitrate (Teatseal and Orbeseal; Pfizer Animal Health, West Ryde, Australia) when used alone, or in the presence of antibiotic dry cow therapy (ADCT), before or at drying off on the incidence of new intramammary infections (IMI), clinical mastitis, and milk somatic cell count (SCC) during lactation. "
01/01/2007 - "This study investigated the effect in heifers of infusion of a bismuth subnitrate teat-canal sealant and bacterial intramammary infection (IMI) precalving on prevalence of postcalving IMI and incidence of clinical mastitis in the first 2 wk postcalving. "
01/01/2008 - "This study investigated the effect of infusion of a bismuth subnitrate teat canal sealant or an injectable antibiotic, or both, in heifers on the cure of existing intramammary infection (IMI), incidence of new IMI, prevalence of postcalving IMI, and incidence of clinical mastitis in the first 2 wk postcalving at the quarter level. "
03/01/2002 - "The efficacy of an internal dry period teat sealer containing bismuth subnitrate (Product A; Teatseal, Cross Vetpharm Group Ltd, Ireland) was compared with a long-acting antibiotic preparation containing cephalonium (Product B; Cepravin Dry Cow, Schering-Plough Ltd, UK), by assessing the number of new intramammary infections (IMI) acquired during the dry period and the number of cases of clinical mastitis during the first 100 d of lactation. "

06/01/1998 - "The addition of bismuth subnitrate to dual oral therapy was also capable of improving the healing of peptic ulcers when compared with dual oral therapy alone (100%, 8/8 vs. 58%, 4/7; P=0.021). "
09/01/1974 - "[Vicalin in the treatment of gastroduodenal ulcer]."
08/01/1963 - "[TREATMENT OF PEPTIC ULCER PATIENTS WITH VIKALIN]."
04/01/1962 - "[Use of Roter in peptic ulcer of the stomach and duodenum]."
11/01/1991 - "As part of an open clinical trial, 18 out of 23 (78%) patients were treated with bismuth subnitrate (3 x 700 mg/d) and 15 out of 25 (60%) patients were treated with cimetidine (1 x 800 mg/d) to cure peptic ulcers linked with H. "

09/01/2004 - "The objective of the study was to validate the model of empathic opportunity (EO) and potential empathic opportunity (PEO) using the Roter Interaction Analysis System (RIAS) in a sample of cancer patients. "
10/01/2006 - "The communicative behaviours of the ROs and the cancer patients were measured by the Roter Interaction Analysis System, and compared before and after the RO training. "
07/01/2004 - "Two samples, sample 1 consisting of 36 cancer patient consultations conducted by four oncologists, and sample 2 consisting 79 consultations of haematology patients conducted by nine specialists, were audiotaped and coded with the Roter Interaction Analysis System (RIAS). "
06/01/2001 - "For this purpose, admission interviews between 53 ward nurses and simulated cancer patients were videotaped and analysed using the Roter Interaction Analysis system, in which a distinction is made between instrumental and affective communication. "
09/01/2000 - "Consultations of 96 consecutive cancer patients were recorded and content analysed by means of the Roter Interaction Analysis System. "

01/01/1991 - "[Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)]."